ZVRA logoZVRA
Zevra Therapeutics Inc

23,644
Loading...
Loading...
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
59

Frequently Asked Questions

What is Market Cap of Zevra Therapeutics Inc?
What is the 52-week high for Zevra Therapeutics Inc?
What is the 52-week low for Zevra Therapeutics Inc?
What is Zevra Therapeutics Inc stock price today?
What was Zevra Therapeutics Inc stock price yesterday?
What is the PE ratio of Zevra Therapeutics Inc?
What is the Price-to-Book ratio of Zevra Therapeutics Inc?
What is the 50-day moving average of Zevra Therapeutics Inc?
How many employess does Zevra Therapeutics Inc has?

Latest ZVRA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.